Ropharma estimates 25 percent profit increase this year

Brasov-based pharmaceutical company Ropharma controlled by businessman Mihai Miron estimates 25 percent increase of profit in 2014 to EUR 9 million and 5 percent increase of sales, to EUR 97 million.

2014-04-30 16:10:37

Last year, the company posted sales worth EUR 93 million, while the profit increased with 3 percent and reached EUR 1.6 million. Ropharma runs two production facilities at Targu Mures and Chisinau, producing pharmaceutical and natural supplements sold through pharmaceutical network of 127 units. Ropharma covers 25 counties and Bucharest, according to the company data.

The structure of sales is achieved 71.4 percent in the pharmaceutical network run by the company and 28.6 percent through distributors. For this year, Ropharma has a budget of RON 7.2 million for investments, out of which half will go for pharmaceutical licenses. Also,m the company plans to launch 13 new products during this year.

Ropharma has a market share of 3.3 percent and on the retail segment; it is the fifth largest company in pharmaceutical segment. As distribution, the company ranks on the eighth position. The company has 900 staff. Mihai Miron owns 31.65 percent of the company, controlling them through two companies, Rimia Investments with 14,12 percent and US-registered ADD Pharmaceuticals with 17,53 percent.

Also, the stakeholders of Ropharma also count the pension fund AZT Viitorul Tau-Allianz with 5,87 percent shares and the private investment fund of ING with 4,99 percent.